Obesity, physical activity and the development of metabolic syndrome: The atherosclerosis risk in communities study

European Journal of Preventive Cardiology

Volumn 17, Issue 3, 2010, Pages 309-313

  Cheriyath, Pramil ^a   Duan, Yinkang ^b   Nambiar, Lakshmi ^a   Liao, Daunping ^b  

^a Pinnacle Health System   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cohort study; metabolic syndrome; obesity; physical activity

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; LEISURE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; ATHEROSCLEROSIS; COMPLICATION; EXERCISE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

ATHEROSCLEROSIS; BODY MASS INDEX; EXERCISE; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 77954033096     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32833189b8     Document Type: Article

References (31)

1. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004; 33: 333–350.
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.
4. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med 1997; 24: 321–336.
5. Rice B, Janssen I, Hudson R, Ross R. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 1999; 22: 684–691.
6. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, controlled trial. Ann Intern Med 2000; 133: 92–103.
7. Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 2002; 4: 407–414.
8. ARIC investigators. The Atherosclerosis Risk in the Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687–702.
9. National Heart Lung and Blood Institute. ARIC manuals of operation: no. 1, general description and study management; no. 2, cohort component procedures; no. 3, surveillance component procedures; no. 4, pulmonary function assessment; no. 5, electrocardiography; no. 6, ultrasound assessment; no. 7, blood collection and processing; no. 8, lipid and lipoprotein determinations; no. 9, hemostasis determinations; no. 10, clinical chemistry determinations; no. 11, sitting blood pressure and postural changes in blood pressure and heart rate; no. 12, quality assurance. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
10. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.
11. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
12. Stone NJ. Focus on lifestyle change and the metabolic syndrome. Endocrinol Metab Clin N Am 2004; 33: 493–508.
13. Kushner RF. Obesity management. Gastroenterol Clin N Am 2004; 36: 191–210.
14. The SAS System for Windows. Cary, NC: SAS Institute Inc.; 2007.
15. Ingelsson E, Ärnlöv J, Sundström J, Risérus U, Michaëlsson K, Byberg L. Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance. Eur J Cardiovas Prev Rehabil 2009; 16: 28–33.
16. Balkau B, Vierron E, Vernay M, Born C, Arondel D, Petrella A, Ducimetiere P. The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the DESIR Study. Eur J Cardiovas Prev Rehabil 2006; 13: 334–340.
17. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C. The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovas Prev Rehabil 2005; 12: 151–158.
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
19. Balkau B, Charles MA. Comments on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16: 442–443.
20. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237–252.
21. International Diabetes federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Meta-syndrome_definition.pdf. [Access 27 October 2006]
22. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936–942.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 2005; 112: 2735–2752.
24. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV, Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003; 26: 861–867.
25. Stolar M. Metabolic syndrome: controversial but useful. CleveClin J Med 2007; 74: 199–208.
26. Busetto L. Visceral obesity and metabolic syndrome: effects of weight loss. Nutr Metabol Cardiovas Dis 2001; 11: 195–204.
27. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351–375.
28. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998; 22: 39–47.
29. Ogden CL, Johnson CL, Carroll MD, Curtin LR, McDowell MA, Talak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549–1555.
30. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–e151.
31. Silventoinen K, Sans S, Tolonen H, Monterde D, Kuulasmaa K, Kesteloot H, Tuomilehto J. WHO MONICA Project. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes 2004; 28: 710–718.